CN Patent
CN1132070A — 药用的水悬浮液制剂
Assigned to Kenvue Brands LLC · Expires 1996-10-02 · 30y expired
What this patent protects
本发明的特征在于药物水悬浮液及其制备方法。该悬浮液含有治疗量的控释扑热息痛粉、有效量的遮味组合物和水,所说扑热息痛粉悬浮于含有稳定悬浮液有效量的黄原胶、羟乙基纤维素和预胶化淀粉的悬浮系统中。
USPTO Abstract
本发明的特征在于药物水悬浮液及其制备方法。该悬浮液含有治疗量的控释扑热息痛粉、有效量的遮味组合物和水,所说扑热息痛粉悬浮于含有稳定悬浮液有效量的黄原胶、羟乙基纤维素和预胶化淀粉的悬浮系统中。
Drugs covered by this patent
- Solosec (SECNIDAZOLE) · Evofem Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.